Navigation Links
Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance
Date:4/15/2008

soon."

Dimebon Showed Statistically Significant Benefit Versus Placebo on All Key Efficacy Endpoints

Medivation previously announced efficacy and safety results from the pivotal, 12-month, double-blind, placebo-controlled trial of Dimebon in 183 patients with mild-to-moderate AD. Dimebon improved the clinical course of Alzheimer's disease patients by causing statistically significant improvements over placebo in each of the five primary aspects of the disease -- memory, thinking, activities of daily living, behavior and overall clinical function. Significant gains over placebo were evident after as little as 12 weeks of treatment, and were maintained after both six months and a full year of treatment. In addition, after six months of treatment, Dimebon patients were significantly better on all five disease aspects than they were at the beginning of the study. The real-world impact of these data was evaluated by independent assessment, including caregiver interviews, which confirmed improvement or stabilization in 81 percent of Dimebon-treated patients after six months of treatment. Importantly, Dimebon's overall benefit compared to placebo continued to increase over time, and was larger at one year than at six months.

Dimebon was well-tolerated throughout the entire one-year treatment period. The majority of adverse events were mild, with dry mouth (18.0 percent Dimebon, 1.1 percent placebo) and depressed mood the most common events. There were significantly fewer serious adverse events in the Dimebon group than in the placebo group at one year.

Medivation is planning to initiate a second, confirmatory pivotal Phase 3 trial of Dimebon in mild-to-moderate AD in the second quarter of 2008 with the goal of completing the trial and applying for U.S. and European marketing approval in 2010. The Company is also evaluating Dimebon in an ongoing Phase 2 clinical trial in mild-to-moderate Huntington's disease. Dimebon is an orally-available small
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
2. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
3. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
4. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
5. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
6. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
7. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
8. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
9. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
10. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
11. Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Ohio , March 2, 2015  Akron Children,s ... Excellence™ (DICOE) by the American College of Radiology (ACR), ... and the second children,s hospital in ... designation.  "Earning recognition from the ACR ... perform at the highest level compared with national benchmarks," ...
(Date:3/2/2015)... , March 2, 2015  Kush Bottles, ... of child-resistant packaging solutions for the marijuana industry, ... Kovacevich , has been nominated for a 2015 ... Excellence in Entrepreneurship Award is designed to recognize ... individuals who, by their creativity and determination, have ...
(Date:3/2/2015)... -- Edison Investment Research, a leading ... full coverage of Abzena  Highlights of ... biotech analysts Christian Glennie and Dr ... offers a range of key services and technologies ... biological products. Antitope (immunogenicity testing, protein engineering, cell ...
Breaking Medicine Technology:Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2Edison Initiates Coverage on Abzena 2
(Date:3/2/2015)... Over the last five years the ultrasound ... to expand their geographic presence and achieve economies of ... $6.2 billion by 2019 at CAGR of 5.1% from ... and Canada and a major part of Europe are ... as Asia-Pacific including China and India, Latin America and ...
(Date:3/2/2015)... This year, the National Multiple Sclerosis Society’s annual ... for people across the country to unite, raise awareness, ... live their best lives. MS Awareness Week is a special ... join the Society’s vision of a world free of MS. ... of the central nervous system, interrupts the flow of information ...
(Date:3/2/2015)... Washington, DC (PRWEB) March 02, 2015 ... the publication of AIS’s Directory of Health Plans: ... comprehensive resource available on the U.S. health plan market, ... operating in the United States. , Available as ... “Executive Summary” of enrollment trends in quick-view tables and ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 A true renaissance ... leader of the 1960s cult rock band Khazad Doom, has ... his determination to persevere despite all odds. His motto throughout ... matter what situation or goal was before him. And that ... is now being passed on to a new generation. , ...
(Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today announced ... serve as chief safety officer. In this role, he ... and guide remediation efforts in all factories from which ... the Alliance continues to bring world-class expertise to factory ... said Alliance Independent Chair Ellen Tauscher. “His role as ...
Breaking Medicine News(10 mins):Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2
... permanent damage, group warns , , SATURDAY, Jan. 17 ... you know how to protect yourself from frostbite? , "It ... the temperature falls below 20 degrees Fahrenheit and the wind ... Taizoon Baxamusa, spokesman for the American Academy of Orthopaedic Surgeons, ...
... Care Collaborative (SCC) will host Spiritual Care Summit ... Springs Resort in Walt Disney World®, FL. This ... the importance of spirituality in all aspects of ... dialogue among all professionals concerned with the spiritual ...
... for a chance to win up to $2,500 and ... enter Fred Hutchinson Cancer Research Center,s "Get Screened" video ... spotlight on the importance of colorectal-cancer screening - has ... the Hutchinson Center,s ongoing awareness campaign - "Your ...
... Plan, Asks Daschle to Investigate.WASHINGTON, Jan. 16 ... representatives to the Federal Interagency Autism Advisory Committee ... vaccine-autism research despite approval of the same studies ... by numerous autism organizations and requested by IACC,s ...
... might be sign of the condition, study says , , ... might one day help doctors detect some forms of ... the developmental disorder, Italian researchers say. , Scientists will ... this month, which looked at just 27 people ...
... numbers on the road, fewer older drivers died in crashes ... in years past, a new Insurance Institute for Highway Safety ... 21 percent during the period, reversing an upward trend, even ... percent. Compared with drivers ages 35-54, older drivers experienced much ...
Cached Medicine News:Health News:Hard, Cold Facts About Frostbite 2Health News:Spiritual Care Summit '09 Underscores Importance of Spirituality in All Aspects of Care 2Health News:Spiritual Care Summit '09 Underscores Importance of Spirituality in All Aspects of Care 3Health News:'Get Screened' Video Contest Deadline Extended to Jan. 30 2Health News:Federal Members of Advisory Committee Block Vaccine-Autism Research, Defy Wishes of Its Own Scientists, Autism Community, and Congress 2Health News:Saliva Test Could Indicate Autism 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 3
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
... Products provide the surgeon ... products for unparalleled fluid ... of fine microsurgical instruments. ... is highly absorbent, fast ...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Medicine Products: